Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Deutsche Boerse AG
  5. Nagarro SE
  6. News
  7. Summary
    NA9   DE000A3H2200

NAGARRO SE

(NA9)
  Report
Delayed Quote. Delayed Deutsche Boerse AG - 12/03 07:43:01 am
180.5 EUR   -2.17%
11/24Nagarro partners with BioT to deliver best-in-class software for medical devices
AQ
11/15NAGARRO : Raised to Buy by Warburg Research
MD
11/15NAGARRO : Jefferies remains Neutral
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about NAGARRO SE
11/24Nagarro partners with BioT to deliver best-in-class software for medical devices
AQ
11/15NAGARRO : Raised to Buy by Warburg Research
MD
11/15NAGARRO : Jefferies remains Neutral
MD
11/12Nagarro posts 33.7% YoY revenue growth in Q3 2021
AQ
11/12NAGARRO : Jefferies sticks Neutral
MD
11/12Nagarro SE posts 33.7% YoY revenue growth in Q3 2021
EQ
11/12Nagarro SE Reports Earnings Results for the Third Quarter and Nine Months Ended Septemb..
CI
11/10NAGARRO SE : Revised guidance FY 2021
EQ
11/10Nagarro SE Revises Revenue Guidance for the Fiscal Year 2021
CI
10/26Nagarro Closes Merger with Operational Management Unit
MT
10/26NAGARRO SE : Nagarro successfully completes its post-spin-off re-organization
EQ
10/19NAGARRO : Warburg Research sticks Neutral
MD
10/18NAGARRO SE : Nagarro Signs Agreements to Acquire the ATCS Group
BU
10/18Advanced Technology Consulting Service and Nagarro Join Forces
CI
10/18NAGARRO : ATCS and Nagarro join forces
AQ
More most relevant news
All news about NAGARRO SE
11/24Nagarro partners with BioT to deliver best-in-class software for medical devices
AQ
11/15NAGARRO : Raised to Buy by Warburg Research
MD
11/15NAGARRO : Jefferies remains Neutral
MD
11/12Nagarro posts 33.7% YoY revenue growth in Q3 2021
AQ
11/12NAGARRO : Jefferies sticks Neutral
MD
11/12Nagarro SE posts 33.7% YoY revenue growth in Q3 2021
EQ
11/12Nagarro SE Reports Earnings Results for the Third Quarter and Nine Months Ended Septemb..
CI
11/10NAGARRO SE : Revised guidance FY 2021
EQ
11/10Nagarro SE Revises Revenue Guidance for the Fiscal Year 2021
CI
10/26Nagarro Closes Merger with Operational Management Unit
MT
More news
News in other languages on NAGARRO SE
12/03NACHBÖRSE/XDAX -0,1% auf 15.162 Pkt - Keine Reaktion auf Index-Änderungen
12/03INDEXÄNDERUNG/DT. BÖRSE : Zooplus werden im MDAX durch Dt. Wohnen ersetzt
11/15OPINIONES DE LOS ANALISTAS DEL DÍA : EDP, Telecom Italia, JDE Peet's, Logitech, Enel, Deli..
11/15Parece que China se despierta
11/15On dirait que la Chine se réveille
11/15AVIS D'ANALYSTES DU JOUR : Alstom, Rémy Cointreau, Chargeurs, Logitech, Delivery Hero, Ape..
11/12Nagarro wächst weiter kräftig - Höhere Kosten bremsen Gewinnanstieg
11/12Nagarro wächst weiter kräftig - höhere Lohnkosten lasten auf Marge
11/12Nagarro SE verzeichnet 33,7 % Umsatzwachstum im 3. Quartal 2021 gegenüber Vorjahr
11/10NACHBÖRSE/XDAX -0,4% auf 16.007 Pkt - SLM Solutions mit 10%-Satz
More news
Analyst Recommendations on NAGARRO SE
11/15NAGARRO : Raised to Buy by Warburg Research
MD
11/15NAGARRO : Jefferies remains Neutral
MD
11/12NAGARRO : Jefferies sticks Neutral
MD
10/19NAGARRO : Warburg Research sticks Neutral
MD
10/08NAGARRO : Jefferies is less optimistic
MD
More recommendations
Press releases
11/24Nagarro partners with BioT to deliver best-in-class software for medical devices
AQ
11/12Nagarro posts 33.7% YoY revenue growth in Q3 2021
AQ
11/12Nagarro SE posts 33.7% YoY revenue growth in Q3 2021
EQ
11/10NAGARRO SE : Revised guidance FY 2021
EQ
10/26NAGARRO SE : Nagarro successfully completes its post-spin-off re-organization
EQ
More press releases